{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T14:11:00Z","timestamp":1788099060433,"version":"build-2803163510"},"reference-count":48,"publisher":"Bioscientifica","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ec.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"<jats:p>Precision medicine employs digital tools and knowledge of a patient\u2019s genetic makeup, environment and lifestyle to improve diagnostic accuracy and to develop individualised treatment and prevention strategies. Precision medicine has improved management in a number of disease areas, most notably in oncology, and it has the potential to positively impact others, including endocrine disorders. The accuracy of diagnosis in young patients with growth disorders can be improved by using biomarkers. Insulin-like growth factor I (IGF-I) is the most widely accepted biomarker of growth hormone secretion, but its predictive value for recombinant human growth hormone treatment response is modest and various factors can affect the accuracy of IGF-I measurements. These factors need to be taken into account when considering IGF-I as a component of precision medicine in the management of growth hormone deficiency. The use of genetic analyses can assist with diagnosis by confirming the aetiology, facilitate treatment decisions, guide counselling and allow prompt intervention in children with pubertal disorders, such as central precocious puberty and testotoxicosis. Precision medicine has also proven useful during the transition of young people with endocrine disorders from paediatric to adult services when patients are at heightened risk of dropping out from medical care. An understanding of the likelihood of ongoing GH deficiency, using tools such as MRI, detailed patient history and IGF-I levels, can assist in determining the need for continued recombinant human growth hormone treatment during the process of transitional care.<\/jats:p>","DOI":"10.1530\/ec-22-0177","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T11:16:20Z","timestamp":1660216580000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":13,"title":["Applying precision medicine to the diagnosis and management of endocrine disorders"],"prefix":"10.1530","volume":"11","author":[{"given":"Martin","family":"Bidlingmaier","sequence":"first","affiliation":[{"name":"Medizinische Klinik und Poliklinik IV, LMU Klinikum, Ludwig-Maximilians University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Gleeson","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Queen Elizabeth Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Claudia","family":"Latronico","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Discipline of Endocrinology and Metabolism, Sao Paulo Medical School, University of Sao Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7902-3376","authenticated-orcid":true,"given":"Martin O","family":"Savage","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"NPJ Digital Medicine","article-title":"Artificial intelligence for precision medicine in neurodevelopmental disorders","volume":"2","author":"Uddin","year":"2019","unstructured":"Uddin MWang YWoodbury-Smith M. Artificial intelligence for precision medicine in neurodevelopmental disorders. NPJ Digital Medicine20192 112. (https:\/\/doi.org\/10.1038\/s41746-019-0191-0)"},{"key":"bib2","series-title":"Frontiers in Pediatrics","article-title":"Digital health for supporting precision medicine in pediatric endocrine disorders: opportunities for improved patient care","volume":"9","author":"Fernandez-Luque","year":"2021","unstructured":"Fernandez-Luque LAl Herbish AAl Shammari RArgente JBin-Abbas BDeeb ADixon DZary NKoledova ESavage MO. Digital health for supporting precision medicine in pediatric endocrine disorders: opportunities for improved patient care. Frontiers in Pediatrics20219 715705. (https:\/\/doi.org\/10.3389\/fped.2021.715705)"},{"key":"bib3","series-title":"Health Affairs","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1377\/hlthaff.2017.1624","article-title":"Precision medicine: from science to value","volume":"37","author":"Ginsburg","year":"2018","unstructured":"Ginsburg GSPhillips KA. Precision medicine: from science to value. Health Affairs201837694\u2013701. (https:\/\/doi.org\/10.1377\/hlthaff.2017.1624)10.1377\/hlthaff.2017.1624"},{"key":"bib4","series-title":"Journal of the American Medical Informatics Association","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/jamia\/ocv213","article-title":"An informatics research agenda to support precision medicine: seven key areas","volume":"23","author":"Tenenbaum","year":"2016","unstructured":"Tenenbaum JDAvillach PBenham-Hutchins MBreitenstein MKCrowgey ELHoffman MAJiang XMadhavan SMattison JENagarajan RAn informatics research agenda to support precision medicine: seven key areas. Journal of the American Medical Informatics Association201623791\u2013795. (https:\/\/doi.org\/10.1093\/jamia\/ocv213)10.1093\/jamia\/ocv213"},{"key":"bib5","series-title":"Clinical Pharmacology and Therapeutics","first-page":"89","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","unstructured":"Biomarkers Definitions Working Group.Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical Pharmacology and Therapeutics20016989\u201395. (https:\/\/doi.org\/10.1067\/mcp.2001.113989)"},{"key":"bib6","series-title":"Endocrine Connections","doi-asserted-by":"publisher","first-page":"R126","DOI":"10.1530\/EC-18-0047","article-title":"Growth Hormone Research Society perspective on biomarkers of GH action in children and adults","volume":"7","author":"Johannsson","year":"2018","unstructured":"Johannsson GBidlingmaier MBiller BMKBoguszewski MCasanueva FFChanson PClayton PEChoong CSClemmons DDattani MGrowth Hormone Research Society perspective on biomarkers of GH action in children and adults. Endocrine Connections20187R126\u2013R134. (https:\/\/doi.org\/10.1530\/EC-18-0047)10.1530\/EC-18-0047"},{"key":"bib7","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1210\/jcem.87.2.8216","article-title":"Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?","volume":"87","author":"Hartman","year":"2002","unstructured":"Hartman MLCrowe BJBiller BMHo KKClemmons DRChipman JJHyposCCS Advisory Board & U.S. HypoCCS Study Group. Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?Journal of Clinical Endocrinology and Metabolism200287477\u2013485. (https:\/\/doi.org\/10.1210\/jcem.87.2.8216)10.1210\/jcem.87.2.8216"},{"key":"bib8","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"1195","article-title":"Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3","volume":"82","author":"Juul","year":"1997","unstructured":"Juul AKastrup KWPedersen SASkakkebaek NE. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3. Journal of Clinical Endocrinology and Metabolism1997821195\u20131201. (https:\/\/doi.org\/10.1210\/jcem.82.4.3892)"},{"key":"bib9","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1530\/EJE-07-0057","article-title":"Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration","volume":"156","author":"Keller","year":"2007","unstructured":"Keller AWu ZKratzsch JKeller EBlum WFKniess APreiss RTeichert JStrasburger CJBidlingmaier M. Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration. European Journal of Endocrinology2007156647\u2013653. (https:\/\/doi.org\/10.1530\/EJE-07-0057)10.1530\/EJE-07-0057"},{"key":"bib10","series-title":"European Journal of Endocrinology","first-page":"13","article-title":"A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency","volume":"144","author":"Schonau","year":"2001","unstructured":"Schonau EWestermann FRauch FStabrey AWassmer GKeller EBramswig JBlum WF & German Lilly Growth Response Study Group. A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency. European Journal of Endocrinology200114413\u201320. (https:\/\/doi.org\/10.1530\/eje.0.1440013)"},{"key":"bib11","series-title":"BMC Endocrine Disorders","article-title":"Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain","volume":"15","author":"Lundberg","year":"2015","unstructured":"Lundberg EKristrom BJonsson BAlbertsson-Wikland K & Study Group. Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain. BMC Endocrine Disorders201515 84. (https:\/\/doi.org\/10.1186\/s12902-015-0080-8)"},{"key":"bib12","series-title":"Pediatric Research","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1203\/00006450-200010000-00010","article-title":"Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities","volume":"48","author":"Wikland","year":"2000","unstructured":"Wikland KAKristrom BRosberg SSvensson BNierop AF. Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities. Pediatric Research200048475\u2013484. (https:\/\/doi.org\/10.1203\/00006450-200010000-00010)10.1203\/00006450-200010000-00010"},{"key":"bib13","series-title":"Endocrine Connections","doi-asserted-by":"publisher","first-page":"R212","DOI":"10.1530\/EC-18-0099","article-title":"The growth hormone-insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders","volume":"7","author":"Blum","year":"2018","unstructured":"Blum WFAlherbish AAlsagheir AEl Awwa AKaplan WKoledova ESavage MO. The growth hormone-insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders. Endocrine Connections20187R212\u2013R222. (https:\/\/doi.org\/10.1530\/EC-18-0099)10.1530\/EC-18-0099"},{"key":"bib14","article-title":"Ringversuche alle 2011","year":"2022","unstructured":"Referenzinstitut f\u00fcr Bioanalytik. Ringversuche alle 2011. Bonn, Germany: RfB, 2022. (available at: https:\/\/www.rfb.bio\/cgi\/displayAnaStats?rv_type=all&rvTypeForDetails=HP&year=2011&rv_num=1&analyte=hGH&searchType=analyte&anaV=4)"},{"key":"bib15","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1530\/EJE-14-0165","article-title":"Clinical evidence-based cutoff limits for GH stimulation tests in children with a backup of results with reference to mass spectrometry","volume":"171","author":"Wagner","year":"2014","unstructured":"Wagner IVPaetzold CGausche RVogel MKoerner AThiery JArsene CGHenrion AGuettler BKeller EClinical evidence-based cutoff limits for GH stimulation tests in children with a backup of results with reference to mass spectrometry. European Journal of Endocrinology2014171389\u2013397. (https:\/\/doi.org\/10.1530\/EJE-14-0165)10.1530\/EJE-14-0165"},{"key":"bib16","series-title":"Clinical Chemistry and Laboratory Medicine","first-page":"1329","article-title":"Reference levels of insulin-like growth factor I in the serum of healthy adults: comparison of four immunoassays","volume":"41","author":"Ranke","year":"2003","unstructured":"Ranke MBOsterziel KJSchweizer RSchuett BWeber KRobbel PVornwald ABlumenstock GElmlinger MW. Reference levels of insulin-like growth factor I in the serum of healthy adults: comparison of four immunoassays. Clinical Chemistry and Laboratory Medicine2003411329\u20131334. (https:\/\/doi.org\/10.1515\/CCLM.2003.203)"},{"key":"bib17","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1210\/jc.2016-1257","article-title":"Reference values for IGF-I serum concentrations: comparison of six immunoassays","volume":"101","author":"Chanson","year":"2016","unstructured":"Chanson PArnoux AMavromati MBrailly-Tabard SMassart CYoung JPiketty MLSouberbielle JC & VARIETE Investigators. Reference values for IGF-I serum concentrations: comparison of six immunoassays. Journal of Clinical Endocrinology and Metabolism20161013450\u20133458. (https:\/\/doi.org\/10.1210\/jc.2016-1257)10.1210\/jc.2016-1257"},{"key":"bib18","series-title":"Endocrine Connections","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1530\/EC-21-0175","article-title":"Reference values for IGF-I serum concentration in an adult population: use of the VARIETE cohort for two new immunoassays","volume":"10","author":"Sabbah","year":"2021","unstructured":"Sabbah NWolf PPiedvache CTrabado SVerdelet TCornu CSouberbielle JCChanson P. Reference values for IGF-I serum concentration in an adult population: use of the VARIETE cohort for two new immunoassays. Endocrine Connections2021101027\u20131034. (https:\/\/doi.org\/10.1530\/EC-21-0175)10.1530\/EC-21-0175"},{"key":"bib19","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1210\/jc.2013-3059","article-title":"Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations","volume":"99","author":"Bidlingmaier","year":"2014","unstructured":"Bidlingmaier MFriedrich NEmeny RTSpranger JWolthers ODRoswall JKorner AObermayer-Pietsch BHubener CDahlgren JReference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations. Journal of Clinical Endocrinology and Metabolism2014991712\u20131721. (https:\/\/doi.org\/10.1210\/jc.2013-3059)10.1210\/jc.2013-3059"},{"key":"bib20","series-title":"Nature","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41586-019-1879-7","article-title":"A brief history of human disease genetics","volume":"577","author":"Claussnitzer","year":"2020","unstructured":"Claussnitzer MCho JHCollins RCox NJDermitzakis ETHurles MEKathiresan SKenny EELindgren CMMacArthur DGA brief history of human disease genetics. Nature2020577179\u2013189. (https:\/\/doi.org\/10.1038\/s41586-019-1879-7)10.1038\/s41586-019-1879-7"},{"key":"bib21","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1530\/EJE-20-0103","article-title":"GENETICS IN ENDOCRINOLOGY: Genetic etiologies of central precocious puberty and the role of imprinted genes","volume":"183","author":"Roberts","year":"2020","unstructured":"Roberts SAKaiser UB. GENETICS IN ENDOCRINOLOGY: Genetic etiologies of central precocious puberty and the role of imprinted genes. European Journal of Endocrinology2020183R107\u2013R117. (https:\/\/doi.org\/10.1530\/EJE-20-0103)10.1530\/EJE-20-0103"},{"key":"bib22","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-15-0488","article-title":"Mutations in the maternally imprinted gene MKRN3 are common in familial central precocious puberty","volume":"174","author":"Simon","year":"2016","unstructured":"Simon DBa IMekhail NEcosse EPaulsen AZenaty DHouang MJesuran Perelroizen Mde Filippo GPSalerno MMutations in the maternally imprinted gene MKRN3 are common in familial central precocious puberty. European Journal of Endocrinology20161741\u20138. (https:\/\/doi.org\/10.1530\/EJE-15-0488)10.1530\/EJE-15-0488"},{"key":"bib23","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1210\/clinem\/dgaa955","article-title":"Genotype-phenotype correlations in central precocious puberty caused by MKRN3 mutations","volume":"106","author":"Seraphim","year":"2021","unstructured":"Seraphim CECanton APMMontenegro LPiovesan MRMacedo DBCunha MGuimaraes ARamos COBenedetti AFFde Castro Leal AGenotype-phenotype correlations in central precocious puberty caused by MKRN3 mutations. Journal of Clinical Endocrinology and Metabolism20211061041\u20131050. (https:\/\/doi.org\/10.1210\/clinem\/dgaa955)10.1210\/clinem\/dgaa955"},{"key":"bib24","series-title":"Lancet: Diabetes and Endocrinology","first-page":"265","article-title":"Causes, diagnosis, and treatment of central precocious puberty","volume":"4","author":"Latronico","year":"2016","unstructured":"Latronico ACBrito VNCarel JC. Causes, diagnosis, and treatment of central precocious puberty. Lancet: Diabetes and Endocrinology20164265\u2013274. (https:\/\/doi.org\/10.1016\/S2213-8587(1500380-0)"},{"key":"bib25","series-title":"Neuroendocrinology","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1159\/000504446","article-title":"Outcomes of patients with central precocious puberty due to loss-of-function mutations in the MKRN3 gene after treatment with gonadotropin-releasing hormone analog","volume":"110","author":"Ramos","year":"2020","unstructured":"Ramos COMacedo DBCanton APMCunha-Silva MAntonini SRRStecchini MFSeraphim CERodrigues TMendonca BBLatronico ACOutcomes of patients with central precocious puberty due to loss-of-function mutations in the MKRN3 gene after treatment with gonadotropin-releasing hormone analog. Neuroendocrinology2020110705\u2013713. (https:\/\/doi.org\/10.1159\/000504446)10.1159\/000504446"},{"key":"bib26","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1210\/jc.2018-02010","article-title":"DLK1 is a novel link between reproduction and metabolism","volume":"104","author":"Gomes","year":"2019","unstructured":"Gomes LGCunha-Silva MCrespo RPRamos COMontenegro LRCanton ALees MSpoudeas HDauber AMacedo DBDLK1 is a novel link between reproduction and metabolism. Journal of Clinical Endocrinology and Metabolism20191042112\u20132120. (https:\/\/doi.org\/10.1210\/jc.2018-02010)10.1210\/jc.2018-02010"},{"key":"bib27","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1210\/jc.2016-3677","article-title":"Paternally inherited DLK1 deletion associated with familial central precocious puberty","volume":"102","author":"Dauber","year":"2017","unstructured":"Dauber ACunha-Silva MMacedo DBBrito VNAbreu APRoberts SAMontenegro LRAndrew MKirby AWeirauch MTPaternally inherited DLK1 deletion associated with familial central precocious puberty. Journal of Clinical Endocrinology and Metabolism20171021557\u20131567. (https:\/\/doi.org\/10.1210\/jc.2016-3677)10.1210\/jc.2016-3677"},{"key":"bib28","series-title":"Human Reproduction","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/humrep\/deaa306","article-title":"Insights from the genetic characterization of central precocious puberty associated with multiple anomalies","volume":"36","author":"Canton","year":"2021","unstructured":"Canton APMKrepischi ACVMontenegro LRCosta SRosenberg CSteunou VSobrier MLSantana LHonjo RSKim CAInsights from the genetic characterization of central precocious puberty associated with multiple anomalies. Human Reproduction202136506\u2013518. (https:\/\/doi.org\/10.1093\/humrep\/deaa306)10.1093\/humrep\/deaa306"},{"key":"bib29","series-title":"American Journal of Human Genetics","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ajhg.2015.07.004","article-title":"Mutations in DDX3X are a common cause of unexplained intellectual disability with gender-specific effects on Wnt signaling","volume":"97","author":"Snijders Blok","year":"2015","unstructured":"Snijders Blok LMadsen EJuusola JGilissen CBaralle DReijnders MRVenselaar HHelsmoortel CCho MTHoischen AMutations in DDX3X are a common cause of unexplained intellectual disability with gender-specific effects on Wnt signaling. American Journal of Human Genetics201597343\u2013352. (https:\/\/doi.org\/10.1016\/j.ajhg.2015.07.004)10.1016\/j.ajhg.2015.07.004"},{"key":"bib30","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1210\/jcem.86.10.7957","article-title":"An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors","volume":"86","author":"Latronico","year":"2001","unstructured":"Latronico ACPinto EMDomenice SFragoso MCMartin RMZerbini MCLucon AMMendonca BB. An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism2001864970\u20134973. (https:\/\/doi.org\/10.1210\/jcem.86.10.7957)10.1210\/jcem.86.10.7957"},{"key":"bib31","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1002\/cncr.33143","article-title":"What 20 years of research has taught us about the TP53 p.R337H mutation","volume":"126","author":"Pinto","year":"2020","unstructured":"Pinto EMZambetti GP. What 20 years of research has taught us about the TP53 p.R337H mutation. Cancer20201264678\u20134686. (https:\/\/doi.org\/10.1002\/cncr.33143)10.1002\/cncr.33143"},{"key":"bib32","series-title":"Science Advances","article-title":"XAF1 as a modifier of p53 function and cancer susceptibility","volume":"6","author":"Pinto","year":"2020","unstructured":"Pinto EMFigueiredo BCChen WGalvao HCRFormiga MNFragoso MCBVAshton-Prolla PRibeiro EMSFFelix GCosta TEBXAF1 as a modifier of p53 function and cancer susceptibility. Science Advances20206 eaba3231. (https:\/\/doi.org\/10.1126\/sciadv.aba3231)"},{"key":"bib33","series-title":"Fertility and Sterility","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.fertnstert.2004.06.069","article-title":"Clinical and hormonal features of selective follicle-stimulating hormone (FSH) deficiency due to FSH beta-subunit gene mutations in both sexes","volume":"83","author":"Berger","year":"2005","unstructured":"Berger KSouza HBrito VNd'Alva CBMendonca BBLatronico AC. Clinical and hormonal features of selective follicle-stimulating hormone (FSH) deficiency due to FSH beta-subunit gene mutations in both sexes. Fertility and Sterility200583466\u2013470. (https:\/\/doi.org\/10.1016\/j.fertnstert.2004.06.069)10.1016\/j.fertnstert.2004.06.069"},{"key":"bib34","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1530\/EJE-09-0648","article-title":"A new FSHbeta mutation in a 29-year-old woman with primary amenorrhea and isolated FSH deficiency: functional characterization and ovarian response to human recombinant FSH","volume":"162","author":"Kottler","year":"2010","unstructured":"Kottler MLChou YYChabre ORichard NPolge CBrailly-Tabard SChanson PGuiochon-Mantel AHuhtaniemi IYoung J. A new FSHbeta mutation in a 29-year-old woman with primary amenorrhea and isolated FSH deficiency: functional characterization and ovarian response to human recombinant FSH. European Journal of Endocrinology2010162633\u2013641. (https:\/\/doi.org\/10.1530\/EJE-09-0648)10.1530\/EJE-09-0648"},{"key":"bib35","series-title":"Hormone Research in Paediatrics","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000447515","article-title":"Time course of central precocious puberty development caused by an MKRN3 gene mutation: a prismatic case","volume":"86","author":"Stecchini","year":"2016","unstructured":"Stecchini MFMacedo DBReis ACAbreu APMoreira ACCastro MKaiser UBLatronico ACAntonini SR. Time course of central precocious puberty development caused by an MKRN3 gene mutation: a prismatic case. Hormone Research in Paediatrics201686126\u2013130. (https:\/\/doi.org\/10.1159\/000447515)10.1159\/000447515"},{"key":"bib36","series-title":"Journal of Pediatric Endocrinology and Metabolism","first-page":"541","article-title":"Preclinical diagnosis of testotoxicosis in a boy with an activating mutation of the luteinizing hormone receptor","volume":"19","author":"Teles","year":"2006","unstructured":"Teles MBrito VNArnhold IJMendonca BBLatronico AC. Preclinical diagnosis of testotoxicosis in a boy with an activating mutation of the luteinizing hormone receptor. Journal of Pediatric Endocrinology and Metabolism200619541\u2013544."},{"key":"bib37","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1530\/eje.1.01829","article-title":"Consensus statement on the management of the GH-treated adolescent in the transition to adult care","volume":"152","author":"Clayton","year":"2005","unstructured":"Clayton PECuneo RCJuul AMonson JPShalet SMTauber M & European Society of Paediatric Endocrinology. Consensus statement on the management of the GH-treated adolescent in the transition to adult care. European Journal of Endocrinology2005152165\u2013170. (https:\/\/doi.org\/10.1530\/eje.1.01829)10.1530\/eje.1.01829"},{"key":"bib38","series-title":"Journal of Adolescent Health","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/1054-139X(93)90143-D","article-title":"Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine","volume":"14","author":"Blum","year":"1993","unstructured":"Blum RWGarell DHodgman CHJorissen TWOkinow NAOrr DPSlap GB. Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine. Journal of Adolescent Health199314570\u2013576. (https:\/\/doi.org\/10.1016\/1054-139x(9390143-d)10.1016\/1054-139X(93)90143-D"},{"key":"bib39","article-title":"Ready Steady Go programme","unstructured":"Transition & Patient Empowerment Innovation Education & Research Network (TIER).Ready Steady Go programme. (available at: https:\/\/www.readysteadygo.net\/)"},{"key":"bib40","series-title":"Journal of Child Health Care","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1367493506060203","article-title":"Growing up and moving on in rheumatology: development and preliminary evaluation of a transitional care programme for a multicentre cohort of adolescents with juvenile idiopathic arthritis","volume":"10","author":"McDonagh","year":"2006","unstructured":"McDonagh JEShaw KLSouthwood TR. Growing up and moving on in rheumatology: development and preliminary evaluation of a transitional care programme for a multicentre cohort of adolescents with juvenile idiopathic arthritis. Journal of Child Health Care20061022\u201342. (https:\/\/doi.org\/10.1177\/1367493506060203)10.1177\/1367493506060203"},{"key":"bib41","series-title":"Clinical Endocrinology","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/cen.14293","article-title":"Less ready for adulthood?-Turner syndrome has an impact on transition readiness","volume":"93","author":"Culen","year":"2020","unstructured":"Culen CHerle MErtl DAFrohlich-Reiterer EBlumel PWagner GHausler G. Less ready for adulthood?-Turner syndrome has an impact on transition readiness. Clinical Endocrinology202093449\u2013455. (https:\/\/doi.org\/10.1111\/cen.14293)10.1111\/cen.14293"},{"key":"bib42","series-title":"Endocrine Practice","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.4158\/GL-2019-0405","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care","volume":"25","author":"Yuen","year":"2019","unstructured":"Yuen KCJBiller BMKRadovick SCarmichael JDJasim SPantalone KMHoffman AR. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. Endocrine Practice2019251191\u20131232. (https:\/\/doi.org\/10.4158\/GL-2019-0405)10.4158\/GL-2019-0405"},{"key":"bib43","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1210\/jc.2007-1003","article-title":"Subnormal serum insulin-like growth factor-I levels in young adults with childhood-onset nonacquired growth hormone (GH) deficiency who recover normal gh secretion may indicate less severe but persistent pituitary failure","volume":"92","author":"Gelwane","year":"2007","unstructured":"Gelwane GGarel CChevenne DArmoogum PSimon DCzernichow PLeger J. Subnormal serum insulin-like growth factor-I levels in young adults with childhood-onset nonacquired growth hormone (GH) deficiency who recover normal gh secretion may indicate less severe but persistent pituitary failure. Journal of Clinical Endocrinology and Metabolism2007923788\u20133795. (https:\/\/doi.org\/10.1210\/jc.2007-1003)10.1210\/jc.2007-1003"},{"key":"bib44","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1210\/jcem.84.4.5614","article-title":"Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults","volume":"84","author":"Maghnie","year":"1999","unstructured":"Maghnie MStrigazzi CTinelli CAutelli MCisternino MLoche SSeveri F. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. Journal of Clinical Endocrinology and Metabolism1999841324\u20131328. (https:\/\/doi.org\/10.1210\/jcem.84.4.5614)10.1210\/jcem.84.4.5614"},{"key":"bib45","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1210\/jc.2009-0602","article-title":"Reassessment of the growth hormone status in young adults with childhood-onset growth hormone deficiency: reappraisal of insulin tolerance testing","volume":"94","author":"Secco","year":"2009","unstructured":"Secco Adi Iorgi NNapoli FCalandra ECalcagno AGhezzi MFrassinetti CFratangeli NParodi SBenassai MReassessment of the growth hormone status in young adults with childhood-onset growth hormone deficiency: reappraisal of insulin tolerance testing. Journal of Clinical Endocrinology and Metabolism2009944195\u20134204. (https:\/\/doi.org\/10.1210\/jc.2009-0602)10.1210\/jc.2009-0602"},{"key":"bib46","series-title":"Clinical Endocrinology","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2265.2009.03686.x","article-title":"Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence","volume":"72","author":"Hogler","year":"2010","unstructured":"Hogler WShaw N. Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence. Clinical Endocrinology201072281\u2013289. (https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03686.x)10.1111\/j.1365-2265.2009.03686.x"},{"key":"bib47","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1210\/jc.2005-2284","article-title":"Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database","volume":"91","author":"Reiter","year":"2006","unstructured":"Reiter EOPrice DAWilton PAlbertsson-Wikland KRanke MB. Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database. Journal of Clinical Endocrinology and Metabolism2006912047\u20132054. (https:\/\/doi.org\/10.1210\/jc.2005-2284)10.1210\/jc.2005-2284"},{"key":"bib48","series-title":"Hormone Research in Paediatrics","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1159\/000322878","article-title":"A comparison of different definitions of growth response in short prepubertal children treated with growth hormone","volume":"75","author":"Bang","year":"2011","unstructured":"Bang PBjerknes RDahlgren JDunkel LGustafsson JJuul AKristrom BTapanainen PAberg V. A comparison of different definitions of growth response in short prepubertal children treated with growth hormone. Hormone Research in Paediatrics201175335\u2013345. (https:\/\/doi.org\/10.1159\/000322878)10.1159\/000322878"}],"container-title":["Endocrine Connections"],"original-title":[],"link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/11\/10\/EC-22-0177.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/11\/10\/EC-22-0177.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/11\/10\/EC-22-0177.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:45:40Z","timestamp":1784555140000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/ec\/article\/1048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":48,"journal-issue":{"issue":"10"},"URL":"https:\/\/doi.org\/10.1530\/ec-22-0177","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,1]]}}}